Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Skin bacteria, specifically Staphylococcus aureus, help in wound healing and hair growth by using IL-1β signaling. Using antibiotics on skin wounds can slow down this natural healing process.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

IL-1 promotes fat cell growth in skin, while WNT inhibits it and encourages scar formation.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

IL-25 helps heal diabetic wounds by improving blood vessel and skin cell functions.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

Blocking IL-8 can reduce skin rashes from cancer treatment.

IL-1 alpha stops hair follicle growth and hair production.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

iL-PRF treatment improves hair growth for androgenetic alopecia.

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

IL-15 helps hair grow longer and stronger by extending the growth phase and reducing cell death.